Lord, Abbett & Co. LLC Adma Biologics, Inc. Transaction History
Lord, Abbett & Co. LLC
- $31.6 Billion
- Q4 2024
A detailed history of Lord, Abbett & Co. LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 2,207,277 shares of ADMA stock, worth $35 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,207,277
Previous 3,094,457
28.67%
Holding current value
$35 Million
Previous $61.9 Million
38.8%
% of portfolio
0.12%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$295 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$288 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$236 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$179 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$87.7 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.11B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...